Anarthron 100 mg/ml Solution for Injection
Anarthron 100 mg/ml Solution for Injection
Authorised
- Pentosan polysulfate sodium
Product identification
Medicine name:
Anarthron 100 mg/ml Solution for Injection
Cartrophen Vet 100 mg/ml Stungulyf, lausn handa hundum
Active substance:
- Pentosan polysulfate sodium
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Pentosan polysulfate sodium100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AX90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Iceland
Package description:
- A 10 ml Ph.Eur. Type 1 clear glass vial fitted with a 20 mm rubber stopper Ph.Eur and closed by a plastic flip off seal attached to an aluminium seal.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Arthropharm (Europe) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Eurovet Animal Health B.V.
- Forte Healthcare Limited
Responsible authority:
- Icelandic Medicines Agency
Authorisation number:
- IS/2/11/008/01
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0355/001
Concerned member states:
-
Austria
-
Belgium
-
France
-
Iceland
-
Norway
-
Poland
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
